nodes	percent_of_prediction	percent_of_DWPC	metapath
Ethosuximide—CYP2E1—liver cancer	0.608	1	CbGaD
Ethosuximide—CYP3A7—Sorafenib—liver cancer	0.0824	0.311	CbGbCtD
Ethosuximide—CYP3A7-CYP3A51P—Sorafenib—liver cancer	0.0824	0.311	CbGbCtD
Ethosuximide—CYP3A5—Sorafenib—liver cancer	0.0618	0.233	CbGbCtD
Ethosuximide—CYP3A4—Sorafenib—liver cancer	0.0241	0.0908	CbGbCtD
Ethosuximide—CYP3A4—Doxorubicin—liver cancer	0.0146	0.0551	CbGbCtD
Ethosuximide—Gastrointestinal symptom NOS—Sorafenib—liver cancer	0.00257	0.0547	CcSEcCtD
Ethosuximide—Abdominal pain upper—Sorafenib—liver cancer	0.001	0.0213	CcSEcCtD
Ethosuximide—Breast disorder—Sorafenib—liver cancer	0.000991	0.0211	CcSEcCtD
Ethosuximide—Abdominal discomfort—Sorafenib—liver cancer	0.000909	0.0193	CcSEcCtD
Ethosuximide—Weight decreased—Sorafenib—liver cancer	0.000858	0.0182	CcSEcCtD
Ethosuximide—Stevens-Johnson syndrome—Sorafenib—liver cancer	0.000838	0.0178	CcSEcCtD
Ethosuximide—Vaginal haemorrhage—Epirubicin—liver cancer	0.000755	0.0161	CcSEcCtD
Ethosuximide—Urinary tract disorder—Sorafenib—liver cancer	0.000749	0.0159	CcSEcCtD
Ethosuximide—Connective tissue disorder—Sorafenib—liver cancer	0.000746	0.0159	CcSEcCtD
Ethosuximide—Urethral disorder—Sorafenib—liver cancer	0.000744	0.0158	CcSEcCtD
Ethosuximide—Rash erythematous—Epirubicin—liver cancer	0.000729	0.0155	CcSEcCtD
Ethosuximide—Erythema multiforme—Sorafenib—liver cancer	0.000718	0.0153	CcSEcCtD
Ethosuximide—Vaginal haemorrhage—Doxorubicin—liver cancer	0.000698	0.0149	CcSEcCtD
Ethosuximide—Immune system disorder—Sorafenib—liver cancer	0.000685	0.0146	CcSEcCtD
Ethosuximide—Mediastinal disorder—Sorafenib—liver cancer	0.000684	0.0146	CcSEcCtD
Ethosuximide—Rash erythematous—Doxorubicin—liver cancer	0.000675	0.0144	CcSEcCtD
Ethosuximide—Mental disorder—Sorafenib—liver cancer	0.000665	0.0141	CcSEcCtD
Ethosuximide—Malnutrition—Sorafenib—liver cancer	0.000661	0.0141	CcSEcCtD
Ethosuximide—Muscle spasms—Sorafenib—liver cancer	0.000635	0.0135	CcSEcCtD
Ethosuximide—Leukopenia—Sorafenib—liver cancer	0.000591	0.0126	CcSEcCtD
Ethosuximide—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.000559	0.0119	CcSEcCtD
Ethosuximide—Hiccups—Epirubicin—liver cancer	0.000559	0.0119	CcSEcCtD
Ethosuximide—Nervous system disorder—Sorafenib—liver cancer	0.000529	0.0112	CcSEcCtD
Ethosuximide—Aplastic anaemia—Epirubicin—liver cancer	0.000524	0.0112	CcSEcCtD
Ethosuximide—Skin disorder—Sorafenib—liver cancer	0.000524	0.0111	CcSEcCtD
Ethosuximide—Hiccups—Doxorubicin—liver cancer	0.000517	0.011	CcSEcCtD
Ethosuximide—Anorexia—Sorafenib—liver cancer	0.000514	0.0109	CcSEcCtD
Ethosuximide—Aplastic anaemia—Doxorubicin—liver cancer	0.000485	0.0103	CcSEcCtD
Ethosuximide—Mental disability—Epirubicin—liver cancer	0.000485	0.0103	CcSEcCtD
Ethosuximide—Decreased appetite—Sorafenib—liver cancer	0.000469	0.00997	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Sorafenib—liver cancer	0.000465	0.0099	CcSEcCtD
Ethosuximide—Fatigue—Sorafenib—liver cancer	0.000465	0.00989	CcSEcCtD
Ethosuximide—Mental disability—Doxorubicin—liver cancer	0.000448	0.00954	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Sorafenib—liver cancer	0.000441	0.00938	CcSEcCtD
Ethosuximide—Urticaria—Sorafenib—liver cancer	0.000428	0.00911	CcSEcCtD
Ethosuximide—Abdominal pain—Sorafenib—liver cancer	0.000426	0.00907	CcSEcCtD
Ethosuximide—Lethargy—Epirubicin—liver cancer	0.000414	0.0088	CcSEcCtD
Ethosuximide—Hypersensitivity—Sorafenib—liver cancer	0.000397	0.00845	CcSEcCtD
Ethosuximide—Asthenia—Sorafenib—liver cancer	0.000387	0.00823	CcSEcCtD
Ethosuximide—Lethargy—Doxorubicin—liver cancer	0.000383	0.00814	CcSEcCtD
Ethosuximide—Ataxia—Epirubicin—liver cancer	0.000381	0.00811	CcSEcCtD
Ethosuximide—Abdominal pain upper—Epirubicin—liver cancer	0.00037	0.00788	CcSEcCtD
Ethosuximide—Diarrhoea—Sorafenib—liver cancer	0.000369	0.00785	CcSEcCtD
Ethosuximide—Breast disorder—Epirubicin—liver cancer	0.000366	0.00779	CcSEcCtD
Ethosuximide—Dizziness—Sorafenib—liver cancer	0.000357	0.00759	CcSEcCtD
Ethosuximide—Ataxia—Doxorubicin—liver cancer	0.000353	0.0075	CcSEcCtD
Ethosuximide—Eosinophilia—Epirubicin—liver cancer	0.000347	0.00738	CcSEcCtD
Ethosuximide—Vomiting—Sorafenib—liver cancer	0.000343	0.00729	CcSEcCtD
Ethosuximide—Abdominal pain upper—Doxorubicin—liver cancer	0.000343	0.00729	CcSEcCtD
Ethosuximide—Rash—Sorafenib—liver cancer	0.00034	0.00723	CcSEcCtD
Ethosuximide—Dermatitis—Sorafenib—liver cancer	0.00034	0.00723	CcSEcCtD
Ethosuximide—Breast disorder—Doxorubicin—liver cancer	0.000339	0.00721	CcSEcCtD
Ethosuximide—Headache—Sorafenib—liver cancer	0.000338	0.00719	CcSEcCtD
Ethosuximide—Pancytopenia—Epirubicin—liver cancer	0.000333	0.00708	CcSEcCtD
Ethosuximide—Eosinophilia—Doxorubicin—liver cancer	0.000321	0.00683	CcSEcCtD
Ethosuximide—Nausea—Sorafenib—liver cancer	0.00032	0.00681	CcSEcCtD
Ethosuximide—Weight decreased—Epirubicin—liver cancer	0.000317	0.00674	CcSEcCtD
Ethosuximide—Drowsiness—Epirubicin—liver cancer	0.000312	0.00665	CcSEcCtD
Ethosuximide—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.00031	0.00659	CcSEcCtD
Ethosuximide—Pancytopenia—Doxorubicin—liver cancer	0.000308	0.00655	CcSEcCtD
Ethosuximide—Haematuria—Epirubicin—liver cancer	0.000298	0.00634	CcSEcCtD
Ethosuximide—Weight decreased—Doxorubicin—liver cancer	0.000293	0.00624	CcSEcCtD
Ethosuximide—Agranulocytosis—Epirubicin—liver cancer	0.000292	0.0062	CcSEcCtD
Ethosuximide—Drowsiness—Doxorubicin—liver cancer	0.000289	0.00615	CcSEcCtD
Ethosuximide—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.000287	0.0061	CcSEcCtD
Ethosuximide—Urinary tract disorder—Epirubicin—liver cancer	0.000277	0.00589	CcSEcCtD
Ethosuximide—Haematuria—Doxorubicin—liver cancer	0.000276	0.00586	CcSEcCtD
Ethosuximide—Connective tissue disorder—Epirubicin—liver cancer	0.000276	0.00586	CcSEcCtD
Ethosuximide—Urethral disorder—Epirubicin—liver cancer	0.000275	0.00585	CcSEcCtD
Ethosuximide—Agranulocytosis—Doxorubicin—liver cancer	0.00027	0.00574	CcSEcCtD
Ethosuximide—Erythema multiforme—Epirubicin—liver cancer	0.000265	0.00564	CcSEcCtD
Ethosuximide—Eye disorder—Epirubicin—liver cancer	0.000262	0.00558	CcSEcCtD
Ethosuximide—Urinary tract disorder—Doxorubicin—liver cancer	0.000256	0.00545	CcSEcCtD
Ethosuximide—Connective tissue disorder—Doxorubicin—liver cancer	0.000255	0.00543	CcSEcCtD
Ethosuximide—Urethral disorder—Doxorubicin—liver cancer	0.000254	0.00541	CcSEcCtD
Ethosuximide—Immune system disorder—Epirubicin—liver cancer	0.000253	0.00539	CcSEcCtD
Ethosuximide—Mediastinal disorder—Epirubicin—liver cancer	0.000253	0.00538	CcSEcCtD
Ethosuximide—Mental disorder—Epirubicin—liver cancer	0.000246	0.00523	CcSEcCtD
Ethosuximide—Erythema multiforme—Doxorubicin—liver cancer	0.000245	0.00522	CcSEcCtD
Ethosuximide—Malnutrition—Epirubicin—liver cancer	0.000244	0.00519	CcSEcCtD
Ethosuximide—Eye disorder—Doxorubicin—liver cancer	0.000243	0.00516	CcSEcCtD
Ethosuximide—Muscle spasms—Epirubicin—liver cancer	0.000235	0.00499	CcSEcCtD
Ethosuximide—Immune system disorder—Doxorubicin—liver cancer	0.000234	0.00499	CcSEcCtD
Ethosuximide—Mediastinal disorder—Doxorubicin—liver cancer	0.000234	0.00498	CcSEcCtD
Ethosuximide—Mental disorder—Doxorubicin—liver cancer	0.000227	0.00484	CcSEcCtD
Ethosuximide—Malnutrition—Doxorubicin—liver cancer	0.000226	0.00481	CcSEcCtD
Ethosuximide—Agitation—Epirubicin—liver cancer	0.000224	0.00477	CcSEcCtD
Ethosuximide—Leukopenia—Epirubicin—liver cancer	0.000219	0.00465	CcSEcCtD
Ethosuximide—Muscle spasms—Doxorubicin—liver cancer	0.000217	0.00462	CcSEcCtD
Ethosuximide—Agitation—Doxorubicin—liver cancer	0.000208	0.00442	CcSEcCtD
Ethosuximide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000206	0.00439	CcSEcCtD
Ethosuximide—Leukopenia—Doxorubicin—liver cancer	0.000202	0.0043	CcSEcCtD
Ethosuximide—Nervous system disorder—Epirubicin—liver cancer	0.000195	0.00416	CcSEcCtD
Ethosuximide—Skin disorder—Epirubicin—liver cancer	0.000194	0.00412	CcSEcCtD
Ethosuximide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000191	0.00406	CcSEcCtD
Ethosuximide—Anorexia—Epirubicin—liver cancer	0.00019	0.00404	CcSEcCtD
Ethosuximide—Nervous system disorder—Doxorubicin—liver cancer	0.000181	0.00385	CcSEcCtD
Ethosuximide—Skin disorder—Doxorubicin—liver cancer	0.000179	0.00381	CcSEcCtD
Ethosuximide—Somnolence—Epirubicin—liver cancer	0.000177	0.00377	CcSEcCtD
Ethosuximide—Anorexia—Doxorubicin—liver cancer	0.000176	0.00374	CcSEcCtD
Ethosuximide—Decreased appetite—Epirubicin—liver cancer	0.000173	0.00369	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Epirubicin—liver cancer	0.000172	0.00366	CcSEcCtD
Ethosuximide—Fatigue—Epirubicin—liver cancer	0.000172	0.00365	CcSEcCtD
Ethosuximide—Somnolence—Doxorubicin—liver cancer	0.000164	0.00349	CcSEcCtD
Ethosuximide—Gastrointestinal pain—Epirubicin—liver cancer	0.000163	0.00347	CcSEcCtD
Ethosuximide—Decreased appetite—Doxorubicin—liver cancer	0.00016	0.00341	CcSEcCtD
Ethosuximide—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000159	0.00339	CcSEcCtD
Ethosuximide—Fatigue—Doxorubicin—liver cancer	0.000159	0.00338	CcSEcCtD
Ethosuximide—Urticaria—Epirubicin—liver cancer	0.000158	0.00337	CcSEcCtD
Ethosuximide—Abdominal pain—Epirubicin—liver cancer	0.000158	0.00335	CcSEcCtD
Ethosuximide—CYP2E1—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.000153	0.00191	CbGpPWpGaD
Ethosuximide—CYP3A5—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.000152	0.00191	CbGpPWpGaD
Ethosuximide—Gastrointestinal pain—Doxorubicin—liver cancer	0.000151	0.00321	CcSEcCtD
Ethosuximide—CACNA1G—Developmental Biology—ABL1—liver cancer	0.000151	0.00189	CbGpPWpGaD
Ethosuximide—CYP3A4—Tryptophan metabolism—CYP2E1—liver cancer	0.000151	0.00189	CbGpPWpGaD
Ethosuximide—Hypersensitivity—Epirubicin—liver cancer	0.000147	0.00312	CcSEcCtD
Ethosuximide—Urticaria—Doxorubicin—liver cancer	0.000146	0.00312	CcSEcCtD
Ethosuximide—Abdominal pain—Doxorubicin—liver cancer	0.000146	0.0031	CcSEcCtD
Ethosuximide—CYP2E1—Metapathway biotransformation—GPX3—liver cancer	0.000145	0.00182	CbGpPWpGaD
Ethosuximide—CYP3A5—Metapathway biotransformation—GPX3—liver cancer	0.000145	0.00182	CbGpPWpGaD
Ethosuximide—CYP3A7—Biological oxidations—GGT1—liver cancer	0.000143	0.00179	CbGpPWpGaD
Ethosuximide—Asthenia—Epirubicin—liver cancer	0.000143	0.00304	CcSEcCtD
Ethosuximide—CYP2E1—Biological oxidations—HPGDS—liver cancer	0.000139	0.00174	CbGpPWpGaD
Ethosuximide—CYP3A5—Biological oxidations—HPGDS—liver cancer	0.000138	0.00173	CbGpPWpGaD
Ethosuximide—Diarrhoea—Epirubicin—liver cancer	0.000136	0.0029	CcSEcCtD
Ethosuximide—Hypersensitivity—Doxorubicin—liver cancer	0.000136	0.00289	CcSEcCtD
Ethosuximide—Asthenia—Doxorubicin—liver cancer	0.000132	0.00281	CcSEcCtD
Ethosuximide—Dizziness—Epirubicin—liver cancer	0.000132	0.0028	CcSEcCtD
Ethosuximide—CACNA1G—Axon guidance—MMP2—liver cancer	0.000131	0.00164	CbGpPWpGaD
Ethosuximide—CYP3A7—Biological oxidations—GSTP1—liver cancer	0.000129	0.00161	CbGpPWpGaD
Ethosuximide—CYP3A7—Metapathway biotransformation—GSTP1—liver cancer	0.000127	0.00159	CbGpPWpGaD
Ethosuximide—Vomiting—Epirubicin—liver cancer	0.000127	0.0027	CcSEcCtD
Ethosuximide—Diarrhoea—Doxorubicin—liver cancer	0.000126	0.00268	CcSEcCtD
Ethosuximide—CYP3A43—Metabolism—CPT1B—liver cancer	0.000126	0.00158	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—GLUL—liver cancer	0.000126	0.00158	CbGpPWpGaD
Ethosuximide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—liver cancer	0.000126	0.00158	CbGpPWpGaD
Ethosuximide—Rash—Epirubicin—liver cancer	0.000126	0.00267	CcSEcCtD
Ethosuximide—Dermatitis—Epirubicin—liver cancer	0.000126	0.00267	CcSEcCtD
Ethosuximide—Headache—Epirubicin—liver cancer	0.000125	0.00266	CcSEcCtD
Ethosuximide—CACNA1G—Developmental Biology—PPARA—liver cancer	0.000123	0.00154	CbGpPWpGaD
Ethosuximide—Dizziness—Doxorubicin—liver cancer	0.000122	0.00259	CcSEcCtD
Ethosuximide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—liver cancer	0.000122	0.00152	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—NR1H4—liver cancer	0.000122	0.00152	CbGpPWpGaD
Ethosuximide—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—liver cancer	0.00012	0.0015	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—GSTA3—liver cancer	0.000119	0.0015	CbGpPWpGaD
Ethosuximide—Nausea—Epirubicin—liver cancer	0.000118	0.00252	CcSEcCtD
Ethosuximide—CYP3A7—Biological oxidations—GSTM1—liver cancer	0.000118	0.00148	CbGpPWpGaD
Ethosuximide—Vomiting—Doxorubicin—liver cancer	0.000117	0.00249	CcSEcCtD
Ethosuximide—CYP3A7—Metapathway biotransformation—GSTM1—liver cancer	0.000117	0.00146	CbGpPWpGaD
Ethosuximide—Rash—Doxorubicin—liver cancer	0.000116	0.00247	CcSEcCtD
Ethosuximide—Dermatitis—Doxorubicin—liver cancer	0.000116	0.00247	CcSEcCtD
Ethosuximide—CACNA1G—Axon guidance—RAF1—liver cancer	0.000116	0.00145	CbGpPWpGaD
Ethosuximide—Headache—Doxorubicin—liver cancer	0.000115	0.00246	CcSEcCtD
Ethosuximide—CACNA1G—Developmental Biology—KDR—liver cancer	0.000114	0.00143	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—MAPK14—liver cancer	0.000113	0.00142	CbGpPWpGaD
Ethosuximide—CYP3A5—Biological oxidations—CYP2E1—liver cancer	0.000113	0.00141	CbGpPWpGaD
Ethosuximide—CYP3A7—Biological oxidations—CYP1A1—liver cancer	0.000112	0.0014	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—MET—liver cancer	0.000112	0.0014	CbGpPWpGaD
Ethosuximide—CYP3A5—Metapathway biotransformation—CYP2E1—liver cancer	0.000111	0.00139	CbGpPWpGaD
Ethosuximide—CYP3A7—Metapathway biotransformation—CYP1A1—liver cancer	0.000111	0.00138	CbGpPWpGaD
Ethosuximide—Nausea—Doxorubicin—liver cancer	0.00011	0.00233	CcSEcCtD
Ethosuximide—CYP3A43—Metabolism—GSTA4—liver cancer	0.000109	0.00137	CbGpPWpGaD
Ethosuximide—CYP3A4—Tryptophan metabolism—CYP1A1—liver cancer	0.000108	0.00136	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—GSTA2—liver cancer	0.000107	0.00133	CbGpPWpGaD
Ethosuximide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—liver cancer	0.000104	0.0013	CbGpPWpGaD
Ethosuximide—CYP2E1—Biological oxidations—GGT1—liver cancer	0.000104	0.0013	CbGpPWpGaD
Ethosuximide—CYP3A5—Biological oxidations—GGT1—liver cancer	0.000103	0.0013	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—GSTA1—liver cancer	0.000103	0.00129	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—NAT2—liver cancer	0.000102	0.00127	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—PPARG—liver cancer	0.000101	0.00127	CbGpPWpGaD
Ethosuximide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—liver cancer	9.87e-05	0.00124	CbGpPWpGaD
Ethosuximide—CACNA1G—Axon guidance—MMP9—liver cancer	9.81e-05	0.00123	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—ALDOB—liver cancer	9.74e-05	0.00122	CbGpPWpGaD
Ethosuximide—CYP3A4—Biological oxidations—NR1H4—liver cancer	9.62e-05	0.00121	CbGpPWpGaD
Ethosuximide—CYP3A4—Biological oxidations—GSTA3—liver cancer	9.46e-05	0.00119	CbGpPWpGaD
Ethosuximide—CYP3A4—Metapathway biotransformation—GSTA3—liver cancer	9.33e-05	0.00117	CbGpPWpGaD
Ethosuximide—CYP2E1—Biological oxidations—GSTP1—liver cancer	9.32e-05	0.00117	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—MMP2—liver cancer	9.31e-05	0.00117	CbGpPWpGaD
Ethosuximide—CYP3A5—Biological oxidations—GSTP1—liver cancer	9.3e-05	0.00116	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—CRABP1—liver cancer	9.29e-05	0.00116	CbGpPWpGaD
Ethosuximide—CYP2E1—Metapathway biotransformation—GSTP1—liver cancer	9.19e-05	0.00115	CbGpPWpGaD
Ethosuximide—CYP3A5—Metapathway biotransformation—GSTP1—liver cancer	9.17e-05	0.00115	CbGpPWpGaD
Ethosuximide—CACNA1G—Axon guidance—VEGFA—liver cancer	8.81e-05	0.0011	CbGpPWpGaD
Ethosuximide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—liver cancer	8.74e-05	0.0011	CbGpPWpGaD
Ethosuximide—CYP3A4—Biological oxidations—GSTA4—liver cancer	8.65e-05	0.00108	CbGpPWpGaD
Ethosuximide—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—liver cancer	8.63e-05	0.00108	CbGpPWpGaD
Ethosuximide—CYP2E1—Biological oxidations—GSTM1—liver cancer	8.56e-05	0.00107	CbGpPWpGaD
Ethosuximide—CYP3A5—Biological oxidations—GSTM1—liver cancer	8.54e-05	0.00107	CbGpPWpGaD
Ethosuximide—CYP3A4—Metapathway biotransformation—GSTA4—liver cancer	8.53e-05	0.00107	CbGpPWpGaD
Ethosuximide—CYP2E1—Metapathway biotransformation—GSTM1—liver cancer	8.44e-05	0.00106	CbGpPWpGaD
Ethosuximide—CYP3A4—Biological oxidations—GSTA2—liver cancer	8.43e-05	0.00106	CbGpPWpGaD
Ethosuximide—CYP3A5—Metapathway biotransformation—GSTM1—liver cancer	8.43e-05	0.00106	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—UGDH—liver cancer	8.38e-05	0.00105	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—RAF1—liver cancer	8.25e-05	0.00103	CbGpPWpGaD
Ethosuximide—CYP3A4—Biological oxidations—GSTA1—liver cancer	8.13e-05	0.00102	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—HPGDS—liver cancer	8.12e-05	0.00102	CbGpPWpGaD
Ethosuximide—CYP2E1—Biological oxidations—CYP1A1—liver cancer	8.12e-05	0.00102	CbGpPWpGaD
Ethosuximide—CYP3A5—Biological oxidations—CYP1A1—liver cancer	8.1e-05	0.00101	CbGpPWpGaD
Ethosuximide—CYP3A4—Biological oxidations—NAT2—liver cancer	8.04e-05	0.00101	CbGpPWpGaD
Ethosuximide—CYP2E1—Metapathway biotransformation—CYP1A1—liver cancer	8e-05	0.001	CbGpPWpGaD
Ethosuximide—CYP3A5—Metapathway biotransformation—CYP1A1—liver cancer	7.99e-05	0.001	CbGpPWpGaD
Ethosuximide—CYP3A4—Metapathway biotransformation—NAT2—liver cancer	7.93e-05	0.000994	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—EPT1—liver cancer	7.88e-05	0.000987	CbGpPWpGaD
Ethosuximide—CACNA1G—Axon guidance—KRAS—liver cancer	7.49e-05	0.000938	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—TAT—liver cancer	7.47e-05	0.000936	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—PSMA4—liver cancer	7.24e-05	0.000907	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—PSMD10—liver cancer	7.24e-05	0.000907	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—CTNNB1—liver cancer	7.14e-05	0.000895	CbGpPWpGaD
Ethosuximide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	7.09e-05	0.000888	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—GOT2—liver cancer	7.04e-05	0.000882	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—MMP9—liver cancer	7e-05	0.000877	CbGpPWpGaD
Ethosuximide—CYP3A4—Metapathway biotransformation—GPX3—liver cancer	6.74e-05	0.000845	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—CYP2E1—liver cancer	6.62e-05	0.00083	CbGpPWpGaD
Ethosuximide—CYP3A4—Biological oxidations—HPGDS—liver cancer	6.43e-05	0.000806	CbGpPWpGaD
Ethosuximide—CACNA1G—Axon guidance—HRAS—liver cancer	6.37e-05	0.000798	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—VEGFA—liver cancer	6.29e-05	0.000788	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—STAT3—liver cancer	6.22e-05	0.00078	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—CYCS—liver cancer	6.2e-05	0.000776	CbGpPWpGaD
Ethosuximide—CACNA1G—Axon guidance—IL6—liver cancer	6.09e-05	0.000763	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—GOT1—liver cancer	6.08e-05	0.000762	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—GGT1—liver cancer	6.08e-05	0.000762	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—UGDH—liver cancer	6.07e-05	0.000761	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—UGDH—liver cancer	6.06e-05	0.000759	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—TGFB1—liver cancer	5.77e-05	0.000723	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—EPT1—liver cancer	5.71e-05	0.000715	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—EPT1—liver cancer	5.7e-05	0.000714	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—GSTP1—liver cancer	5.46e-05	0.000684	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—TAT—liver cancer	5.41e-05	0.000678	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—TAT—liver cancer	5.4e-05	0.000676	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—TNF—liver cancer	5.39e-05	0.000675	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—HMOX1—liver cancer	5.39e-05	0.000675	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—KRAS—liver cancer	5.34e-05	0.00067	CbGpPWpGaD
Ethosuximide—CYP3A4—Biological oxidations—CYP2E1—liver cancer	5.24e-05	0.000657	CbGpPWpGaD
Ethosuximide—CYP3A4—Metapathway biotransformation—CYP2E1—liver cancer	5.17e-05	0.000648	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—GLUL—liver cancer	5.08e-05	0.000636	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—CPT1B—liver cancer	5.08e-05	0.000636	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—GSTM1—liver cancer	5.02e-05	0.000629	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—NR1H4—liver cancer	4.9e-05	0.000613	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—GSTA3—liver cancer	4.81e-05	0.000603	CbGpPWpGaD
Ethosuximide—CYP3A4—Biological oxidations—GGT1—liver cancer	4.81e-05	0.000603	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—CYP1A1—liver cancer	4.76e-05	0.000596	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—HRAS—liver cancer	4.54e-05	0.000569	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—MTHFR—liver cancer	4.43e-05	0.000556	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—GSTA4—liver cancer	4.4e-05	0.000552	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—PPARA—liver cancer	4.35e-05	0.000545	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—IL6—liver cancer	4.35e-05	0.000545	CbGpPWpGaD
Ethosuximide—CYP3A4—Biological oxidations—GSTP1—liver cancer	4.32e-05	0.000542	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—GSTA2—liver cancer	4.29e-05	0.000537	CbGpPWpGaD
Ethosuximide—CYP3A4—Metapathway biotransformation—GSTP1—liver cancer	4.26e-05	0.000534	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—GSTA1—liver cancer	4.14e-05	0.000519	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—NAT2—liver cancer	4.09e-05	0.000513	CbGpPWpGaD
Ethosuximide—CACNA1G—Developmental Biology—AKT1—liver cancer	4.01e-05	0.000503	CbGpPWpGaD
Ethosuximide—CYP3A4—Biological oxidations—GSTM1—liver cancer	3.97e-05	0.000498	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—ALDOB—liver cancer	3.92e-05	0.000492	CbGpPWpGaD
Ethosuximide—CYP3A4—Metapathway biotransformation—GSTM1—liver cancer	3.92e-05	0.000491	CbGpPWpGaD
Ethosuximide—CYP3A4—Biological oxidations—CYP1A1—liver cancer	3.77e-05	0.000472	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—CRABP1—liver cancer	3.74e-05	0.000469	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—PIK3CG—liver cancer	3.73e-05	0.000467	CbGpPWpGaD
Ethosuximide—CYP3A4—Metapathway biotransformation—CYP1A1—liver cancer	3.71e-05	0.000465	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—CPT1B—liver cancer	3.68e-05	0.000461	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—GLUL—liver cancer	3.68e-05	0.000461	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—CPT1B—liver cancer	3.67e-05	0.00046	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—GLUL—liver cancer	3.67e-05	0.00046	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—PPARG—liver cancer	3.6e-05	0.000451	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—NR1H4—liver cancer	3.55e-05	0.000444	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—NR1H4—liver cancer	3.54e-05	0.000443	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—GSTA3—liver cancer	3.49e-05	0.000437	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—GSTA3—liver cancer	3.48e-05	0.000436	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—PIK3CD—liver cancer	3.28e-05	0.00041	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—HPGDS—liver cancer	3.27e-05	0.00041	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—ALB—liver cancer	3.23e-05	0.000405	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—GSTA4—liver cancer	3.19e-05	0.0004	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—GSTA4—liver cancer	3.18e-05	0.000399	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—GSTA2—liver cancer	3.11e-05	0.000389	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—GSTA2—liver cancer	3.1e-05	0.000389	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—GSTA1—liver cancer	3e-05	0.000376	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—GSTA1—liver cancer	2.99e-05	0.000375	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—NAT2—liver cancer	2.96e-05	0.000371	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—NAT2—liver cancer	2.96e-05	0.000371	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—PSMD10—liver cancer	2.92e-05	0.000365	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—PSMA4—liver cancer	2.92e-05	0.000365	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—PIK3CB—liver cancer	2.86e-05	0.000358	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—ALDOB—liver cancer	2.84e-05	0.000356	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—GOT2—liver cancer	2.84e-05	0.000355	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—ALDOB—liver cancer	2.84e-05	0.000355	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—UGDH—liver cancer	2.82e-05	0.000353	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—CRABP1—liver cancer	2.71e-05	0.00034	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—CRABP1—liver cancer	2.71e-05	0.000339	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—CYP2E1—liver cancer	2.67e-05	0.000334	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—EPT1—liver cancer	2.65e-05	0.000332	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—TAT—liver cancer	2.51e-05	0.000314	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—CYCS—liver cancer	2.5e-05	0.000313	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—GOT1—liver cancer	2.45e-05	0.000307	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—GGT1—liver cancer	2.45e-05	0.000307	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—HPGDS—liver cancer	2.37e-05	0.000297	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—HPGDS—liver cancer	2.36e-05	0.000296	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—GSTP1—liver cancer	2.2e-05	0.000276	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—HMOX1—liver cancer	2.17e-05	0.000272	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—PSMA4—liver cancer	2.11e-05	0.000265	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—PSMD10—liver cancer	2.11e-05	0.000265	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—PSMA4—liver cancer	2.11e-05	0.000264	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—PSMD10—liver cancer	2.11e-05	0.000264	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—GOT2—liver cancer	2.05e-05	0.000257	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—GOT2—liver cancer	2.05e-05	0.000257	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—GSTM1—liver cancer	2.02e-05	0.000253	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—CYP2E1—liver cancer	1.93e-05	0.000242	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—CYP1A1—liver cancer	1.92e-05	0.00024	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—CYCS—liver cancer	1.81e-05	0.000226	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—CYCS—liver cancer	1.8e-05	0.000226	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—MTHFR—liver cancer	1.79e-05	0.000224	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—GGT1—liver cancer	1.77e-05	0.000222	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—GOT1—liver cancer	1.77e-05	0.000222	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—GGT1—liver cancer	1.77e-05	0.000222	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—GOT1—liver cancer	1.77e-05	0.000222	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—PPARA—liver cancer	1.75e-05	0.00022	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—PIK3CA—liver cancer	1.74e-05	0.000218	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—GLUL—liver cancer	1.71e-05	0.000214	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—CPT1B—liver cancer	1.71e-05	0.000214	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—NR1H4—liver cancer	1.65e-05	0.000206	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—GSTA3—liver cancer	1.62e-05	0.000203	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—GSTP1—liver cancer	1.59e-05	0.0002	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—GSTP1—liver cancer	1.59e-05	0.000199	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—HMOX1—liver cancer	1.57e-05	0.000197	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—HMOX1—liver cancer	1.57e-05	0.000196	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—PIK3CG—liver cancer	1.5e-05	0.000188	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—GSTA4—liver cancer	1.48e-05	0.000185	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—GSTM1—liver cancer	1.46e-05	0.000183	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—GSTM1—liver cancer	1.46e-05	0.000183	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—PPARG—liver cancer	1.45e-05	0.000181	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—GSTA2—liver cancer	1.44e-05	0.000181	CbGpPWpGaD
Ethosuximide—CYP3A43—Metabolism—AKT1—liver cancer	1.42e-05	0.000178	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—GSTA1—liver cancer	1.39e-05	0.000174	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—CYP1A1—liver cancer	1.39e-05	0.000174	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—CYP1A1—liver cancer	1.39e-05	0.000174	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—NAT2—liver cancer	1.38e-05	0.000172	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—PIK3CD—liver cancer	1.32e-05	0.000165	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—ALDOB—liver cancer	1.32e-05	0.000165	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—ALB—liver cancer	1.3e-05	0.000163	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—MTHFR—liver cancer	1.29e-05	0.000162	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—MTHFR—liver cancer	1.29e-05	0.000162	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—PPARA—liver cancer	1.27e-05	0.000159	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—PPARA—liver cancer	1.27e-05	0.000159	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—CRABP1—liver cancer	1.26e-05	0.000158	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—PIK3CB—liver cancer	1.15e-05	0.000144	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—HPGDS—liver cancer	1.1e-05	0.000138	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—PIK3CG—liver cancer	1.09e-05	0.000136	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—PIK3CG—liver cancer	1.08e-05	0.000136	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—PPARG—liver cancer	1.05e-05	0.000131	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—PPARG—liver cancer	1.05e-05	0.000131	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—PSMD10—liver cancer	9.8e-06	0.000123	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—PSMA4—liver cancer	9.8e-06	0.000123	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—PIK3CD—liver cancer	9.56e-06	0.00012	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—PIK3CD—liver cancer	9.54e-06	0.000119	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—GOT2—liver cancer	9.53e-06	0.000119	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—ALB—liver cancer	9.43e-06	0.000118	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—ALB—liver cancer	9.41e-06	0.000118	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—CYP2E1—liver cancer	8.96e-06	0.000112	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—CYCS—liver cancer	8.39e-06	0.000105	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—PIK3CB—liver cancer	8.33e-06	0.000104	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—PIK3CB—liver cancer	8.31e-06	0.000104	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—GOT1—liver cancer	8.23e-06	0.000103	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—GGT1—liver cancer	8.23e-06	0.000103	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—GSTP1—liver cancer	7.39e-06	9.26e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—HMOX1—liver cancer	7.29e-06	9.13e-05	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—PIK3CA—liver cancer	7.01e-06	8.78e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—GSTM1—liver cancer	6.79e-06	8.51e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—CYP1A1—liver cancer	6.44e-06	8.07e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—MTHFR—liver cancer	6e-06	7.52e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—PPARA—liver cancer	5.89e-06	7.38e-05	CbGpPWpGaD
Ethosuximide—CYP3A7—Metabolism—AKT1—liver cancer	5.73e-06	7.18e-05	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—PIK3CA—liver cancer	5.08e-06	6.36e-05	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—PIK3CA—liver cancer	5.07e-06	6.35e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—PIK3CG—liver cancer	5.04e-06	6.32e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—PPARG—liver cancer	4.87e-06	6.1e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—PIK3CD—liver cancer	4.43e-06	5.56e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—ALB—liver cancer	4.38e-06	5.48e-05	CbGpPWpGaD
Ethosuximide—CYP2E1—Metabolism—AKT1—liver cancer	4.15e-06	5.2e-05	CbGpPWpGaD
Ethosuximide—CYP3A5—Metabolism—AKT1—liver cancer	4.14e-06	5.19e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—PIK3CB—liver cancer	3.86e-06	4.84e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—PIK3CA—liver cancer	2.36e-06	2.95e-05	CbGpPWpGaD
Ethosuximide—CYP3A4—Metabolism—AKT1—liver cancer	1.92e-06	2.41e-05	CbGpPWpGaD
